FDA Fast Talk: Health Advisories with Unclear Advice

FDA is trying to get safety messages out to consumers more rapidly. A recent warning on Nexium and Prilosec shows how complicated these early warnings can be.

What happens when FDA makes an announcement about a possible health issue but really doesn’t have anything to say? FDA’s recent review of AstraZeneca PLC ’s esomeprazole (Nexium) underscores exactly how squeezed the agency is right now.

On August 9, FDA put out a health advisory and scheduled a media call with associate director for safety policy...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet